A case of COVID-19 reinfection in a hemodialysis patient: the role of antibody in SARS-CoV-2 infection
In conclusion, we experienced a case of COVID-19 reinfection in a hemodialysis patient 81 days after the first episode and showed the kinetics and role of antibodies in SARS-CoV-2 infection. Further studies are needed to understand SARS-CoV-2 reinfection risk in hemodialysis patients and its clinical significance.
Source: CEN Case Reports - Category: Urology & Nephrology Source Type: research
More News: COVID-19 | Dialysis | Hemodialysis | Intensive Care | Outbreaks | Respiratory Medicine | SARS | Study | Urology & Nephrology